Company type: public
All of Merchavia’s investments are in companies that were developed by Cleveland Clinic Innovations.
Controlling main share holders: Goldstein family
Chairman of Merchavia: Rani Lifshits
CEO of Merchavia: Eli Arad
Cleveland Diagnostics is developing a breakthrough technology to discover new class of diagnostics tests with high sensitivity and specificity for many cancers – early on, when cancer is still curable
Ocon medical Develops, manufactures, and commercializes innovative women’s health products.
based on its proprietary flexible Nitinol platform, IUB (Intra Uterine Ball).
The first product, the Ballerine is a long term (5 years in current markets) copper-based hormone-free intrauterine contraceptive. It is currently sold in 30 countries across Europe, South Africa, and Israel. To date, over ~95,000 women have used Ballerine.
The next product based on the same platform is a treatment of abnormal uterine bleeding (AUB) with SEAD (Spherical Endometrial Ablation Device), the product is in PHASE IIa clinical study.
Other APIs could be added to the delivery system, including a hormone-free, long-acting agent or other drugs that require targeted delivery in the uterine cavity.
Aura smart air
Aura aims to redefine air quality management and to become the World’s Smartest Air Management Platform, A Data-Driven Air Quality Platform Based on User Behavior Algorithm.
Aura detects indoor and outdoor air quality based on real-time monitoring through an array of smart sensors.
Heidy is a unique air quality assistant app that personalizes the Aura device precisely to your needs and health necessities. After completing the Heidy questionnaire, the Aura device will act and provide relevant recommendations, customizing the device based on your personal profile.
Air Quality data is monitored in real-time to provide smart insights and recommendations.
Scientific research found that Aura Air detects, captures and disinfects 99.9% of viruses, bacteria, mold and VOCs so you can breathe freely. Ideal for every indoor space, it removes airborne particles as small as 0.3 microns, including allergens and CoronaVirus.
TrainPain is a new science based digital product designed to improve mental and emotional well-being for people living with neuropathic and fibromyalgia pain.
The medical technological approach is based on a perception known in the literature, according to which the nervous system is particularly sensitive in chronic pain patients, and by training the system, pain levels can be reduced. TrainPain Promotes Brain Health Through Neuroplasticity Exercises
TrainPain finalized first clinical trial with High Satisfaction and engagement among Test Users. Trainpain are in process of initiating more clinical trials in University of Liege, Mt Sinai Hospital and University of Haifa.
EFA develops RevDx- The First Affordable Hand-Held Device for on-the-spot CBC tests (Complete Blood Count) with no expertise required.
CBC is the most requested test worldwide and physician’s “best practice”. Helps diagnosing infectious diseases, hematological malignancies and immune system deficiencies.
EFA’s diagnostic system addresses the global need to minimize the overuse of antibiotics and combines several advantages of ease of use and advanced technology, including a simple operation that does not require special training, and a connective and fully portable device.
EfA’s product: RevDx (Revolutionary Diagnostics), is a mobile, portable, handheld, end-point solution that includes an innovative method to perform an automatic computerized “microscopy like” inspection, including a whole blood sampling and an automatic diagnosis of blood count and other applications to be followed.
VEOLI aims to redefine medical cannabis delivery by migrating novel technologies developed for the pharma industry to the cannabis space.
Veoli develops a unique rechargeable electrical cannabis inhaler device, the device produces an accurate dosage, has Bluetooth connectivity to VEOLI App which manages dosing and capsules supply.
Since there is no heating in the process, there is no change in the properties of the cannabis and no production of byproducts that usually occur during heating or burning.
Veoli was established in Sanara Ventures technological incubator, in which the Teva Industries and Philips are partners.
Nervio develops the world’s first AI-DRIVEN neuromonitoring solution. Making neuromonitoring accessible and affordable for any operating room worldwide.
Neuromonitoring is the only tool to prevent nerve injury during surgery. Spine, neck & other surgeries involve high risk of nerve injury. Neuromonitoring is a real-time, complex, error-prone process which is highly dependent on the user’s experience and expertise.
The company was established in Mor research application fund from Clalit health organization and entered to the eHealth Ventures incubator with a unique collaboration between Clalit and Maccabi the biggest healthcare organizations in Israel, also partners in eHealth Ventures are Cleveland Clinic and Amgen pharmaceutical.